Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study-Reference-Cited by-同舟云学术

Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study

Published:2021-05 Issue: Volume:35 Page:100855
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Schauwvlieghe A.^ORCID,Dunbar A.,Storme E.,Vlak A.,Aerts R.^ORCID,Maertens J.,Sciot B.,Van Der Wel T.,Papageorgiou G.,Moors I.,Cornelissen J.J.,Rijnders B.J.A.,Mercier T.

Publisher

Elsevier BV

Subject

General Medicine

Reference15 articles.

1. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America;Freifeld;Clin Infect Dis,2011

2. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European conference on infections in leukemia;Averbuch;Haematologica,2013

3. Antimicrobial stewardship: bridging the gap between quality care and cost;Goff;Curr Opin Infect Dis,2011

4. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (how long study): an open-label, randomised, controlled phase 4 trial;Aguilar-Guisado;Artic Lancet Haematol,2017

5. Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study;Slobbe;Eur J Cancer,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early stoppage of empirical antibiotic therapy at clinical improvement in paediatric leukaemia patients with high-risk febrile neutropenia (ESAT-HR-FN study): Study protocol of a single centre investigator initiated randomised open label non-inferiority trial;Heliyon;2024-08

2. Antibiotic practice and stewardship in the management of neutropenic fever: a survey of US institutions;Infection Control & Hospital Epidemiology;2024-08-01

3. Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies;Transplant Infectious Disease;2024-02-13

4. Efficacy of an antimicrobial stewardship intervention for early adaptation of antibiotic therapy in high-risk neutropenic patients;Antimicrobial Resistance & Infection Control;2024-01-17

5. Risky business: The impact of antimicrobial prescribing on multidrug‐resistant Gram‐negative BSIs in acute myeloid leukemia patients;Transplant Infectious Disease;2023-07-12